← Back to the feed
Default4579RaQualia Pharma Inc.

Raqualia Pharma Revises Dividend to 26.4

P
Pulse Newswire
✓ Validated English translation
Filed 11:30 JST
1 min read

TOKYO (Pulse News Wire) — Raqualia Pharma Inc. [4579.T] corrected its dividend result for the fiscal year ending December 2026.

The dividend was revised to ¥26.4 from ¥16.9 per share. The correction was disclosed on January 18, 2026 after errors were identified in the interim earnings report.

PDFOriginal disclosureTDnet filing · Japanese · 11:30 JSTView original ↗
End of article
More from the feed
Default4579
Raqualia Pharma signs drug development deals with Lazarus Pharmaceuticals
Jun 12
Default4579
Raqualia Pharma to Collaborate with RIKEN on Drug Discovery Tech Development
Jun 02
Default4579
Raqualia Pharma Receives Milestone Payment From Velovia Pharma Over License Exercise
May 20